FDA Approved: XHANCE — Supplemental Application (OptiNose US, Inc.)

View source ↗

Summary

FDA approves a supplemental New Drug Application for XHANCE (fluticasone propionate) by OptiNose US, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• XHANCE (Fluticasone propionate)

Snippet

SUPPL AP for XHANCE (FLUTICASONE PROPIONATE)